In Julius Melnitzer's Law Times article, "Glaxo Case Sets Principle for Dealing with Transfer Pricing", Claire Kennedy discusses the Federal Court of Appeal's July 26 transfer-pricing ruling in GlaxoSmithKline Inc. v. Canada, stating, "What is important is the Federal Court's acknowledgment that transfer-pricing  decisions don't exist in a vacuum and don't operate outside business realities."